Vertex Pharmaceuticals Effective Income Tax Rate Reconciliation, FDII, Percent remained flat by 0.0% to 0.3% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 95.4%, from 7.1% to 0.3%. Over 2 years (FY 2023 to FY 2025), Effective Income Tax Rate Reconciliation, FDII, Percent shows a downward trend with a -12.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests a higher proportion of income qualifies for FDII tax benefits, improving tax efficiency.
The percentage point impact of the Foreign-Derived Intangible Income (FDII) deduction on the company's effective tax rat...
Standard tax reconciliation metric for U.S. companies with significant export-related income.
other_effective_income_tax_rate_reconciliation_fdii_percent| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | 1.7% | 28.3% | 1.3% |
| YoY Change | — | >999% | -95.4% |